Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Erlotinib | 1 | uM | 7 | 156.25 | 15.92 | 47.00 | 169.42 | 0.3102 | 0.3615 |
| MCF 10A | Lapatinib | 0.1 | uM | 7 | 156.25 | 15.92 | 297.33 | 169.42 | 1.7948 | 1.3601 |
| MCF 10A | 17-AAG | 1 | uM | 7 | 156.25 | 15.92 | 23.67 | 169.42 | 0.1346 | 0.0922 |
| MCF 10A | Erlotinib | 0.31623 | uM | 7 | 156.25 | 15.92 | 110.33 | 169.42 | 0.6880 | 0.7709 |
| MCF 10A | Lapatinib | 0.0016596 | uM | 7 | 156.25 | 15.92 | 248.67 | 169.42 | 1.5022 | 1.2571 |
| MCF 10A | Lapatinib | 0.031623 | uM | 7 | 156.25 | 15.92 | 394.67 | 169.42 | 2.6365 | 1.5663 |
| MCF 10A | 17-AAG | 0.01 | uM | 7 | 156.25 | 15.92 | 42.00 | 169.42 | 0.2526 | 0.3306 |
| MCF 10A | 17-AAG | 0.31623 | uM | 7 | 156.25 | 15.92 | 29.00 | 169.42 | 0.1872 | 0.1884 |
| MCF 10A | Erlotinib | 0.0033113 | uM | 7 | 156.25 | 15.92 | 182.00 | 169.42 | 1.0770 | 1.0368 |
| MCF 10A | Erlotinib | 0.1 | uM | 7 | 156.25 | 15.92 | 218.33 | 169.42 | 1.3315 | 1.1759 |
| MCF 10A | Erlotinib | 10 | uM | 7 | 156.25 | 15.92 | 51.67 | 169.42 | 0.3140 | 0.4023 |
| MCF 10A | Erlotinib | 19.9526 | uM | 7 | 156.25 | 15.92 | 31.00 | 169.42 | 0.1878 | 0.2156 |
| MCF 10A | Lapatinib | 0.0033113 | uM | 7 | 156.25 | 15.92 | 212.67 | 169.42 | 1.2726 | 1.1463 |
| MCF 10A | Lapatinib | 0.01 | uM | 7 | 156.25 | 15.92 | 235.00 | 169.42 | 1.5377 | 1.2134 |
| MCF 10A | 17-AAG | 0.0016596 | uM | 7 | 156.25 | 15.92 | 117.00 | 169.42 | 0.6866 | 0.7876 |
| MCF 10A | 17-AAG | 0.0033113 | uM | 7 | 156.25 | 15.92 | 80.67 | 169.42 | 0.4964 | 0.5901 |
| MCF 10A | 17-AAG | 0.031623 | uM | 7 | 156.25 | 15.92 | 45.67 | 169.42 | 0.2917 | 0.3627 |
| MCF 10A | 17-AAG | 0.1 | uM | 7 | 156.25 | 15.92 | 34.00 | 169.42 | 0.2099 | 0.2509 |
| MCF 10A | 17-AAG | 3.1623 | uM | 7 | 156.25 | 15.92 | 26.67 | 169.42 | 0.1600 | 0.1624 |
| MCF 10A | 17-AAG | 10 | uM | 7 | 156.25 | 15.92 | 37.33 | 169.42 | 0.2262 | 0.2872 |
| MCF 10A | Erlotinib | 0.01 | uM | 7 | 156.25 | 15.92 | 218.00 | 169.42 | 1.2989 | 1.1611 |
| MCF 10A | Erlotinib | 0.031623 | uM | 7 | 156.25 | 15.92 | 145.67 | 169.42 | 0.8856 | 0.9294 |
| MCF 10A | Erlotinib | 3.1623 | uM | 7 | 156.25 | 15.92 | 44.00 | 169.42 | 0.2810 | 0.3441 |
| MCF 10A | Lapatinib | 1 | uM | 7 | 156.25 | 15.92 | 340.33 | 169.42 | 1.9537 | 1.3301 |
| MCF 10A | Lapatinib | 0.31623 | uM | 7 | 156.25 | 15.92 | 289.33 | 169.42 | 1.6330 | 1.2466 |